Literature DB >> 17575374

Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias.

Tomohiro Handa1, Sonoko Nagai, Shinji Miki, Seigen Ueda, Naoichiro Yukawa, Yasutaka Fushimi, Yutaka Ito, Kosuke Ohta, Tsuneyo Mimori, Michiaki Mishima, Takateru Izumi.   

Abstract

OBJECT: This study was undertaken to investigate the frequency of pulmonary hypertension (PH), and clinical parameters associated with PH in patients with idiopathic interstitial pneumonias (IIPs) and collagen vascular disease-associated interstitial pneumonias (CVD-IPs). PATIENTS AND METHODS: Retrospective analyses were performed in 163 consecutively enrolled patients (78 IIPs and 85 CVD-IPs) who were being evaluated for PH by Doppler echocardiography. PH was defined as an estimated systolic pulmonary artery pressure (sPAP) of > or = 40 mmHg. The frequency of PH was evaluated and clinical parameters were compared between patients with PH and those without PH.
RESULTS: Among patients successfully evaluated for sPAP by echocardiography, 20 of 70 (28%) patients with IIPs and 17 of 80 (21%) patients with CVD-IPs had PH. Among patients with IIP and CVD-IP, those with PH were more frequently treated with supplemental oxygen. Patients with IIP who had PH tended to be older and had decreased % diffusion capacity of carbon monoxide (%DLCO). Additionally, in patients with IIP, sPAP was negatively correlated with %DLCO. However, this association was not found in patients with CVD-IP. Patients with CVD-IP who had PH were predominantly male.
CONCLUSION: PH was frequently observed in patients with both IIPs (28%) and CVD-IPs (21%) in the chronic phase of the disease. PH should be evaluated in patients with IPs who need supplemental oxygen, IIP patients with decreased diffusing capacity, and in patients with CVD-IP.

Entities:  

Mesh:

Year:  2007        PMID: 17575374     DOI: 10.2169/internalmedicine.46.6342

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Estimation of pulmonary vascular resistance in patients with pulmonary fibrosis by phase-contrast magnetic resonance imaging.

Authors:  Yuichiro Ayukawa; Sadayuki Murayama; Nanae Tsuchiya; Satomi Yara; Jiro Fujita
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

2.  Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia.

Authors:  Robert W Hallowell; Robert M Reed; Mostafa Fraig; Maureen R Horton; Reda E Girgis
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

Review 3.  Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension.

Authors:  Sylvia M Nikkho; Manuel J Richter; Eric Shen; Steven H Abman; Katerina Antoniou; Jonathan Chung; Peter Fernandes; Paul Hassoun; Howard M Lazarus; Horst Olschewski; Lucilla Piccari; Mitchell Psotka; Rajan Saggar; Oksana A Shlobin; Norman Stockbridge; Patrizio Vitulo; Carmine Dario Vizza; Stephen J Wort; Steven D Nathan
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

4.  Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection.

Authors:  Raj Parikh; Ippokratis Konstantinidis; David M O'Sullivan; Harrison W Farber
Journal:  Pulm Circ       Date:  2022-10-01       Impact factor: 2.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.